Tag:
Abbott Vascular
Latest Headlines
Latest Headlines
Stent advances expected to prop up European market
First, the bad news: The overall European coronary stent market is expected to dip to about $490 million by 2016, even with growth in procedure numbers. That market number will be the result of a
Abbott's BVS used in first patient in Japan
The first patient in Japan has been treated with Abbott ( $ABT ) Vascular's ABSORB bioresorbable vascular scaffold (BVS), which restores blood flow by opening a clogged vessel. The BVS also provides
Abbott gets FDA OK for renal stent system
Abbott Vascular has received the FDA's blessing for the RX Herculink Elite renal stent system for the treatment of renal artery stenosis in patients with uncontrolled hypertension. It is the first
Abbott Vascular cuts 120 jobs
Abbott Vascular, a division of Abbott Laboratories, is cutting 120 permanent jobs from its stent-making operations in California. The layoffs include reductions at Abbott's Temecula, French Valley
